The programming for the conference will focus on “Next Generation Tools for Regenerative Medicine”.
SCB will be a featured speaker.
SCB is offering is a 2-day in-person course focused on practical application of the FDA-recognized ISO cell counting standards ISO 20391 part 1&2. Join us at Montgomery College in Germantown, MD (20 miles north of Washington, DC).
Register now as space is limited.
On November 6-7, 2025, SCB, in collaboration with experts from NIST, is offering a Hands-On ISO Cell Counting Implementation course at Montgomery College Germantown Campus in Maryland, 20 miles north of Washington, DC. This course is designed to supplement the on-demand, "Implementation of the ISO Cell Counting Standards" Course and will consist of two full days of in-person learning.
The Society for Cryobiology’s annual CRYO meeting is the world’s premier meeting devoted to all aspects of low temperature biology and medicine, comprising both the fundamental science of ice formation as well as branching into niche sub-disciplines.
ISO/TC 276 international meeting
The 2025 meeting theme is Transforming Regenerative Medicine and Biomanufacturing.
SCB will be a featured speaker.
28th annual meeting of ASGCT
VIRTUAL EVENT
This webinar will discuss the VCS process, what the stakeholders need to know, and how to develop one. A case study of an actual international consensus standard development of tissue-specific MSC biobanking, characterization, terminology with extensive and iterative input from ISCT will also be presented.
SCB will be a featured speaker.
Taking place at ASTM’s November 2024 Committee Week
The inaugural Raw Materials for Cell & Gene Therapy Summit will help the industry bridge the knowledge gap within the raw material community by delving into critical issues such as supplier selection, material quality, safety assurance and required good manufacturing practices for materials to develop regulatory compliant and high-quality cell and gene therapies.
The 6th Gene Therapy Analytical Development & CMC Summit will unite 250+ analytical development, CMC, QC, and process development experts to showcase innovative analytical and process development methods, assess their readiness, and ultimately guarantee safety, quality, efficacy, and consistency of gene therapies to regulators.
At this international ISO conference, SCB will discuss multiple standards efforts.
ISO/TC 276 Biotechnology focuses on standards for biotechnology processes and topics including terms and definitions; biobanks and bioresources; analytical methods; bioprocessing; data processing including annotation, analysis, validation, comparability and integration; and metrology.
This event will focus on Extractables & Leachables, followed by a day dedicated to analytical and process platforming. SCB will be speaking at this event.
SCB Will be presenting at ISCT's annual meeting at the Contributing to FDA’s Standards Recognition Program for Regenerative Medicine Therapies (SRP-RMT) Roundtable, as well as a poster presentation, and available at booth 222 to promote the recently released standards implementation courses.
After the tremendous success of their previous events, ARMI|BioFabUSA is thrilled to welcome people back for another unforgettable gathering. Get ready to dive deep into the future of biomanufacturing as ARMI/BiofabUSA brings you the latest insights, trends, challenges, and opportunities in this rapidly evolving sector. The 2024 MITM promises to be a three-day extravaganza filled with visionary content that will leave participants inspired and informed.
SCB and FDA will explain the CBER guidance document on recognized voluntary consensus standards and an initial list of recognized standards.
The Standards Coordinating Body (SCB) for Regenerative Medicine, the U.S. Food and Drug Administration (FDA), and the National Institute of Standards and Technology (NIST) are holding a workshop, co-organized by the United States Pharmacopeia (USP), on November 16 and 17. The workshop will be held at the USP headquarters in Rockville, MD.
Regenerative medicine, including cell and gene therapy, provides an unprecedented potential to treat or cure previously intractable diseases, such as cancer and rare genetic diseases. Advances in manufacturing technologies, measurements, and standards are needed to ensure the safety, quality, and consistency of this new class of therapies and to reduce cost. NIST in collaboration with FDA has been working with the broader industry and stakeholders to develop global standards underpinned by a robust measurement infrastructure. NIST hosts multiple technical Consortia to jointly develop precompetitive technologies, measurement solutions, and standards to accelerate technology development and translation.
The world’s leaders in stem cell research convene once a year for the ISSCR Annual Meeting to help advance stem cell research and regenerative medicine to improve human health.
The American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting is the premier event for professionals in gene and cell therapy.
This conference will bring together a diverse, interdisciplinary group of researchers with interests in organogenesis, tumorigenesis, stem cell function and therapy to catalyze collaboration and cross-fertilize ideas. The meeting will focus particularly on developmental, metabolic, genomic and epigenomic mechanisms regulating the function of cancer cells and stem cells.
The ISBioTech 12th spring meeting will be held in Norfolk, VA.
The Bioprocessing Summit Europe brings together 500+ bioproduction, analytical and formulation professionals to advance the manufacture, quality and control of biological and genetic therapies.
The inaugural Viral Vector Process Development Summit is the premier platform for Upstream and Downstream Process Development Scientists, Viral Vector Technology, CMC and Production Leads to share their lessons learned and inspirations to overcome bottlenecks.
This meeting will provide you with the must-know takeaways from the basic biology to biomarkers to clinical trial design to overcome the clinical setbacks and produce a blockbuster TGF-β therapeutic.
The inaugural Next Generation Ophthalmic Drug Delivery Summit will help ophthalmic drug developers overcome translational challenges of developing novel long-lasting ophthalmic therapies via novel delivery methods to reduce healthcare burden and increase patient compliance.
Two back-to-back conferences and a foundational training seminar on the critical challenges facing the analysis, characterization, quality control, scale-up, and manufacture of cell and gene therapies.
This dedicated meeting is your one-stop shop to see the key advances and learn from the industry's leaders to solve your differentiation, expansion, quality and engineering challenges.
By signing up, you’re agreeing to receive email from SCB. But rest assured: we respect your privacy.
